clarithromycin has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuno, T; Hara, N; Hidaka, K; Mitsuyama, T | 1 |
1 other study(ies) available for clarithromycin and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
Article | Year |
---|---|
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide.
Topics: Anti-Bacterial Agents; Benzoates; Calcium; Cells, Cultured; Clarithromycin; Endothelium, Vascular; Erythromycin; Humans; Imidazoles; L-Lactate Dehydrogenase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Nitric Oxide; Pulmonary Artery; Superoxides | 1997 |